Protein kinase C alpha (PKCα) regulates growth and invasion of endometrial cancer cells

Journal of Cellular Physiology

Volumn 220, Issue 1, 2009, Pages 112-118

  Haughian, James M ^a   Bradford, Andrew P ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; PROTEIN KINASE C ALPHA; CCND1 PROTEIN, HUMAN; PRKCA PROTEIN, HUMAN; SMALL INTERFERING RNA;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENDOMETRIUM CELL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CELL ADHESION; CELL MOTION; ENDOMETRIUM TUMOR; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; PROMOTER REGION; RABBIT; RNA INTERFERENCE; TUMOR CELL LINE;

ANIMALS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D1; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; NEOPLASM INVASIVENESS; PROMOTER REGIONS, GENETIC; PROTEIN KINASE C-ALPHA; RABBITS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 65549108795     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21741     Document Type: Article

References (57)

1. Albitar L, Pickett G, Morgan M, Davies S, Leslie KK. 2007. Models representing type I and type II human endometrial cancers: Ishikawa H and Hec50co cells. Gynecol Oncol 106:52-64.
2. Amos S, Mut M, diPierro CG, Carpenter JE, Xiao A, Kohutek ZA, Redpath GT, Zhao Y, Wang J, Shaffrey ME, Hussaini IM. 2007. Protein kinase C-alpha-mediated regulation of low-density lipoprotein receptor related protein and urokinase increases astrocytoma invasion. Cancer Res 67:10241-10251.
3. Bamberger AM, Bamberger CM, Wald M, Kratzmeier M, Schulte HM. 1996. Protein kinase C (PKC) isoenzyme expression pattern as an indicator of proliferative activity in uterine tumor cells. Mol Cell Endocrinol 123:81-88.
4. Bamberger AM, Bamberger CM, Schulte HM. 1998. Molecular mechanisms of proliferation in endometrial tumour cells. Hum Reprod Update 4:526-531.
5. Broom OJ, Massoumi R, Sjolander A. 2006. Alpha2beta1 integrin signalling enhances cyclooxygenase-2 expression in intestinal epithelial cells. J Cell Physiol 209:950-958.
6. Dean N, McKay R, Miraglia L, Howard R, Cooper S, Giddings J, Nicklin P, Meister L, Ziel R, Geiger T, Muller M, Fabbro D. 1996. Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression. Cancer Res 56:3499-3507.
7. Dennis JU, Dean NM, Bennett CF, Griffith JW, Lang CM, Welch DR. 1998. Human melanoma metastasis is inhibited following ex vivo treatment with an antisense oligonucleotide to protein kinase C-alpha. Cancer Lett 128:65-70.
8. Ellenson LH, Wu TC. 2004. Focus on endometrial and cervical cancer. Cancer Cell 5:533-538.
9. Erkanli S, Bolat F, Kayaselcuk F, Demirhan B, Kuscu E. 2007. COX-2 and survivin are overexpressed and positively correlated in endometrial carcinoma. Gynecol Oncol 104:320-325.
10. Fournier DB, Chisamore M, Lurain JR, Rademaker AW, Jordan VC, Tonetti DA. 2001. Protein kinase C alpha expression is inversely related to ER status in endometrial carcinoma: Possible role in AP-1-mediated proliferation of ER-negative endometrial cancer. Gynecol Oncol 81:366-372.
11. Frey MR, Clark JA, Leontieva O, Uronis JM, Black AR, Black JD. 2000. Protein kinase C signaling mediates a program of cell cycle withdrawal in the intestinal epithelium. J Cell Biol 151:763-778.
12. Gong Y, Alkhalaf B, Murphy LJ, Murphy LC. 1992. Differential effects of phorbol esters on proliferation and calcyclin expression in human endometrial carcinoma cells. Cell Growth Differ 3:847-853.
13. Griner EM, Kazanietz MG. 2007. Protein kinaseCand other diacylglycerol effectors in cancer. Nat Rev Cancer 7:281-294.
14. Gruber JR, Ohno S, Niles RM. 1992. Increased expression of protein kinase C alpha plays a key role in retinoic acid-induced melanoma differentiation. J Biol Chem 267:13356-13360.
15. Haughian JM, Jackson TA, Koterwas DM, Bradford AP. 2006. Endometrial cancer cell survival and apoptosis is regulated by protein kinase C alpha and delta. Endocr Relat Cancer 13:1251-1267.
16. Hecht JL, Mutter GL. 2006. Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol 24:4783-4791.
17. Hodges RR, Raddassi I, Zoukhri D, Toker A, Kazlauskas A, Dartt DA. 2004. Effect of overexpression of constitutively active PKCalpha on rat lacrimal gland protein secretion. Invest Ophthalmol Vis Sci 45:3974-3981.
18. Hussaini IM, Trotter C, Zhao Y, Abdel-Fattah R, Amos S, Xiao A, Agi CU, Redpath GT, Fang Z, Leung GK, Lopes MB, Laws ER Jr. 2007. Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line. Am J Pathol 170:356-365.
19. Ishino K, Fukazawa H, Shikano M, Ohba M, Kuroki T, Uehara Y. 2002. Enhancement of anchorage-independent growth of human pancreatic carcinoma MIA PaCa-2 cells by signaling from protein kinase C to mitogen-activated protein kinase. Mol Carcinog 34:180-186.
20. Jackson TA, Schweppe RE, Koterwas DM, Bradford AP. 2001. Fibroblast growth factor activation of the rat PRL promoter is mediated by PKCdelta. Mol Endocrinol 15:1517-1528.
21. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. 2007. Cancer statistics, 2007. CA Cancer J Clin 57:43-66.
22. Jiang XH, Tu SP, Cui JT, Lin MC, Xia HH, Wong WM, Chan AO, Yuen MF, Jiang SH, Lam SK, Kung HF, Soh JW, Weinstein IB, Wong BC. 2004. Antisense targeting protein kinase C alpha and beta1 inhibits gastric carcinogenesis. Cancer Res 64:5787-5794.
23. Jorgensen K, Skrede M, Cruciani V, Mikalsen SO, Slipicevic A, Florenes VA. 2005. Phorbol ester phorbol-12-myristate-13-acetate promotes anchorage-independent growth and survival of melanomas through MEK-independent activation of ERK1/2. Biochem Biophys Res Commun 329:266-274.
24. Karahan N, Guney M, Baspinar S, Oral B, Kapucuoglu N, Mungan T. 2007. Expression of gelatinase (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) in endometrial carcinoma. Eur J Gynaecol Oncol 28:184-188.
25. Kermorgant S, Aparicio T, Dessirier V, Lewin MJ, Lehy T. 2001. Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease overproduction. Evidence for PI3 kinase and PKC involvement. Carcinogenesis 22:1035-1042.
26. Koivunen J, Aaltonen V, Peltonen J. 2006. Protein kinase C (PKC) family in cancer progression. Cancer Lett 235:1-10.
27. Lee RJ, Albanese C, Stenger RJ, Watanabe G, Inghirami G, Haines GK III, Webster M, Muller WJ, Brugge JS, Davis RJ, Pestell RG. 1999. pp60v-src induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. J Biol Chem 274:7341-7350.
28. Mackay HJ, Twelves CJ. 2007. Targeting the protein kinase C family: Are we there yet? Nat Rev Cancer 7:554-562.
29. Mahanivong C, Chen HM, Yee SW, Pan ZK, Dong Z, Huang S. 2008. Protein kinase C alpha-CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells. Oncogene 27:1273-1280.
30. Mandil R, Ashkenazi E, Blass M, Kronfeld I, Kazimirsky G, Rosenthal G, Umansky F, Lorenzo PS, Blumberg PM, Brodie C. 2001. Protein kinase Calpha and protein kinase Cdelta play opposite roles in the proliferation and apoptosis of glioma cells. Cancer Res 61:4612-4619.
31. Massague J. 2004. G1 cell-cycle control and cancer. Nature 432:298-306.
32. Michie AM, Nakagawa R. 2005. The link between PKCalpha regulation and cellular transformation. Immunol Lett 96:155-162.
33. Monaghan H, MacWhinnie N, Williams AR. 2007. The role of matrix metalloproteinases-2, -7 and -9 and beta-catenin in high grade endometrial carcinoma. Histopathology 50:348-357.
34. Mountain DJ, Singh M, Menon B, Singh K. 2007. Interleukin-1beta increases expression and activity of matrix metalloproteinase-2 in cardiac microvascular endothelial cells: Role of PKCalpha/beta1 and MAPKs. Am J Physiol Cell Physiol 292:C867-C875.
35. Ng T, Shima D, Squire A, Bastiaens PI, Gschmeissner S, Humphries MJ, Parker PJ. 1999. PKCalpha regulates beta1 integrin-dependent cell motility through association and control of integrin traffic. EMBO J 18:3909-3923.
36. Nishida M, Kasahara K, Oki A, Satoh T, Arai Y, Kubo T. 1996. Establishment of eighteen clones of Ishikawa cells. Hum Cell 9:109-116.
37. Nishimura Y, Watanabe J, Jobo T, Kato N, Fujisawa T, Kamata Y, Kuramoto H. 2004. Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis. Anticancer Res 24:2185-2191.
38. Ohno S, Ohno Y, Suzuki N, Inagawa H, Kohchi C, Soma G, Inoue M. 2005. Multiple roles of cyclooxygenase-2 in endometrial cancer. Anticancer Res 25:3679-3687.
39. Ozuysal S, Ozturk H, Bilgin T, Filiz G. 2005. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables. Arch Gynecol Obstet 271:123-126.
40. Prat J, Gallardo A, Cuatrecasas M, Catasus L. 2007. Endometrial carcinoma: Pathology and genetics. Pathology 39:72-87.
41. Ruhul Quddus M, Latkovich P, Castellani WJ, James Sung C, Steinhoff MM, Briggs RC, Miranda RN. 2002. Expression of cyclin D1 in normal, metaplastic, hyperplastic endometrium and endometrioid carcinoma suggests a role in endometrial carcinogenesis. Arch Pathol Lab Med 126:459-463.
42. Sakurada A, Hamada H, Fukushige S, Yokoyama T, Yoshinaga K, Furukawa T, Sato S, Yajima A, Sato M, Fujimura S, Horii A. 1999. Adenovirus-mediated delivery of the PTEN gene inhibits cell growth by induction of apoptosis in endometrial cancer. Int J Oncol 15:1069-1074.
43. Satyaswaroop PG, Fleming H, Bressler RS, Gurpide E. 1978. Human endometrial cancer cell cultures for hormonal studies. Cancer Res 38:4367-4375.
44. Shin Y, Yoon SH, Choe EY, Cho SH, Woo CH, Rho JY, Kim JH. 2007. PMA-induced upregulation of MMP-9 is regulated by a PKCalpha-NF-kappaB cascade in human lung epithelial cells. Exp Mol Med 39:97-105.
45. Sliva D. 2004. Signaling pathways responsible for cancer cell invasion as targets for cancer therapy. Curr Cancer Drug Targets 4:327-336.
46. Soh JW, Weinstein IB. 2003. Roles of specific isoforms of protein kinase C in the transcriptional control of cyclin D1 and related genes. J Biol Chem 278:34709-34716.
47. Tan M, Li P, Sun M, Yin G, Yu D. 2006. Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors. Oncogene 25:3286-3295.
48. Tang CH, Wei Y. 2008. The urokinase receptor and integrins in cancer progression. Cell Mol Life Sci 65:1916-1932.
49. Van Themsche C, Mathieu I, Parent S, Asselin E. 2007. Transforming growth factor-beta3 increases the invasiveness of endometrial carcinoma cells through phosphatidylinositol 3-kinase-dependent up-regulation of X-linked inhibitor of apoptosis and protein kinase cdependent induction of matrix metalloproteinase-9. J Biol Chem 282:4794-4802.
50. Wang XY, Repasky E, Liu HT. 1999. Antisense inhibition of protein kinase Calpha reverses the transformed phenotype in human lung carcinoma cells. Exp Cell Res 250:253-263.
51. Way DL, Grosso DS, Davis JR, Surwit EA, Christian CD. 1983. Characterization of a new human endometrial carcinoma (RL95-2) established in tissue culture. In Vitro 19:147-158.
52. Ways DK, Kukoly CA, deVente J, Hooker JL, Bryant WO, Posekany KJ, Fletcher DJ, Cook PP, Parker PJ. 1995. MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. J Clin Invest 95:1906-1915.
53. Wieser F, Vigne JL, Wenzl R, Huber J, Taylor RN. 2005. Effects of phorbol dibutyrate on cell proliferation, apoptosis, and tumor necrosis factor-alpha expression in human endometrial adenocarcinoma cells. J Soc Gynecol Investig 12:370-375.
54. Wu H, Chen Y, Liang J, Shi B, Wu G, Zhang Y, Wang D, Li R, Yi X, Zhang H, Sun L, Shang Y. 2005. Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis. Nature 438:981-987.
55. Wu W, Slomovitz BM, Soliman PT, Schmeler KM, Celestino J, Milam MR, Lu KH. 2006. Correlation of cyclin D1 and cyclin D3 overexpression with the loss of PTEN expression in endometrial carcinoma. Int J Gynecol Cancer 16:1668-1672.
56. Wu TT, Hsieh YH, Hsieh YS, Liu JY. 2008. Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma. J Cell Biochem 103:9-20.
57. Zeng X, Xu H, Glazer RI. 2002. Transformation of mammary epithelial cells by 3-phosphoinositide-dependent protein kinase-1 (PDK1) is associated with the induction of protein kinase Calpha. Cancer Res 62:3538-3543.